112 related articles for article (PubMed ID: 7263980)
1. Clofazimine treatment of pyoderma gangrenosum.
Kark EC; Davis BR
J Am Acad Dermatol; 1981 Sep; 5(3):346-8. PubMed ID: 7263980
[No Abstract] [Full Text] [Related]
2. Pyoderma gangrenosum treated with clofazimine: clinical evaluation of 7 cases.
Rasmussen I
Acta Derm Venereol; 1983; 63(6):552-3. PubMed ID: 6198851
[TBL] [Abstract][Full Text] [Related]
3. Clofazimine in dermatitis ulcerosa (pyoderma gangrenosum). Open clinical trial.
Mensing H
Dermatologica; 1988; 177(4):232-6. PubMed ID: 3066646
[TBL] [Abstract][Full Text] [Related]
4. Splenic infarction and tissue accumulation of crystals associated with the use of clofazimine (Lamprene; B663) in the treatment of pyoderma gangrenosum.
McDougall AC; Horsfall WR; Hede JE; Chaplin AJ
Br J Dermatol; 1980 Feb; 102(2):227-30. PubMed ID: 7387877
[TBL] [Abstract][Full Text] [Related]
5. Pyoderma gangrenosum treated with clofazimine. Report of three cases.
Kark EC; Davis BR; Pomeranz JR
J Am Acad Dermatol; 1981 Feb; 4(2):152-9. PubMed ID: 7217385
[TBL] [Abstract][Full Text] [Related]
6. A case of clofazimine enteropathy.
Hameed A; Beach FX; Kennedy RH; Barry RE
Int J Clin Pract; 1998 Sep; 52(6):439-40. PubMed ID: 9894387
[TBL] [Abstract][Full Text] [Related]
7. Hyperimmunoglobulin E and impaired neutrophil functions in a case of pyoderma gangrenosum: effect of clofazimine.
Berbis P; Mege JL; Capo C; Kaplanski S; Bongrand P; Privat Y
J Am Acad Dermatol; 1988 Mar; 18(3):574-6. PubMed ID: 3351016
[No Abstract] [Full Text] [Related]
8. Clofazimine. A new agent for the treatment of pyoderma gangrenosum.
Michaëlsson G; Molin L; Ohmann S; Gip L; Lindström B; Skogh M; Trolin I
Arch Dermatol; 1976 Mar; 112(3):344-9. PubMed ID: 1259447
[TBL] [Abstract][Full Text] [Related]
9. [Pyoderma gangrenosum: 2 cases with perineal localization].
Cola B; Porzio F; Farella S
Ann Ital Chir; 1980; 52(4):465-75. PubMed ID: 7224433
[No Abstract] [Full Text] [Related]
10. [Lamprène. New therapeutic indications (excluding leprosy)].
Beurey J; Weber M; Chaulieu Y
LARC Med; 1982 Jan; 2(1):48-50, 53, 55. PubMed ID: 6219260
[No Abstract] [Full Text] [Related]
11. Radiological abnormalities of the ileum associated with the use of clofazimine (Lamprene; B663) in the treatment of skin ulceration due to Mycobacterium ulcerans.
de Bergeyck E; Janssens PG; de Muynck A
Lepr Rev; 1980 Sep; 51(3):221-8. PubMed ID: 7442414
[No Abstract] [Full Text] [Related]
12. Clofazimine in the treatment of pyoderma gangrenosum.
Thomsen K; Rothenborg HW
Arch Dermatol; 1979 Jul; 115(7):851-2. PubMed ID: 453894
[TBL] [Abstract][Full Text] [Related]
13. [Use of lamprène in dermatology].
Chavaz P; Laugier P
LARC Med; 1982 Jan; 2(1):56-7. PubMed ID: 7162254
[No Abstract] [Full Text] [Related]
14. Orange/black discolouration of the bowel (at laparotomy) due to clofazimine.
Merrett MN; King RW; Farrell KE; Zeimer H; Guli E
Aust N Z J Surg; 1990 Aug; 60(8):638-9. PubMed ID: 2390049
[TBL] [Abstract][Full Text] [Related]
15. [Pyoderma gangrenosum: Clofazimine therapy].
Beurey J; Weber M; Delrous JL; Chaulieu Y
Ann Dermatol Venereol; 1977 Oct; 104(10):631-4. PubMed ID: 610518
[TBL] [Abstract][Full Text] [Related]
16. Pyoderma gangrenosum: successful treatment with intralesional steroids.
Jennings JL
J Am Acad Dermatol; 1983 Oct; 9(4):575-80. PubMed ID: 6630619
[TBL] [Abstract][Full Text] [Related]
17. Clearing of pyoderma gangrenosum by intralesional cyclosporin A.
Mrowietz U; Christophers E
Br J Dermatol; 1991 Nov; 125(5):499. PubMed ID: 1751361
[No Abstract] [Full Text] [Related]
18. The treatment of pyoderma gangrenosum with sodium cromoglycate.
de Cock KM; Thorne MG
Br J Dermatol; 1980 Feb; 102(2):231-3. PubMed ID: 6770886
[TBL] [Abstract][Full Text] [Related]
19. [Azathioprine treatment of ulcerative dermatitis (pyoderma gangrenosum)].
Schöpf E; Schulz HJ; Schulz KH
Hautarzt; 1969 Dec; 20(12):558-63. PubMed ID: 5405393
[No Abstract] [Full Text] [Related]
20. Pyoderma gangrenosum associated with ulcerative colitis: treatment with disodium cromoglycate.
Cave DR; Burakoff R
Am J Gastroenterol; 1987 Aug; 82(8):802-4. PubMed ID: 3111244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]